BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12556751)

  • 1. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
    French MH; Faxon DP
    Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM
    Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotics for PCI: an indigenous direct thrombin inhibitor (DTI) makes the cut.
    Mukherjee D
    Indian Heart J; 2008; 60(4):284-6. PubMed ID: 19242003
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
    Bittl JA; Ahmed WH
    Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming heparin limitations in high-risk percutaneous coronary intervention: the alternative strategy-- replacing heparin with bivalirudin.
    Henry TD
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():19B-29B. PubMed ID: 11967387
    [No Abstract]   [Full Text] [Related]  

  • 8. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antithrombotic drugs].
    Taliani MR; Agnelli G
    Recenti Prog Med; 1999 Feb; 90(2):86-93. PubMed ID: 10208099
    [No Abstract]   [Full Text] [Related]  

  • 11. Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.
    Bates ER
    Curr Cardiol Rep; 2001 Sep; 3(5):348-54. PubMed ID: 11504570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications.
    McCann CJ; Menown IB
    Vasc Health Risk Manag; 2008; 4(2):305-13. PubMed ID: 18561506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should bivalirudin replace heparin during percutaneous coronary interventions?
    Antman EM
    JAMA; 2003 Feb; 289(7):903-5. PubMed ID: 12588276
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.
    O'Shea SI; Ortel TL; Kovalik EC
    Semin Dial; 2003; 16(1):61-7. PubMed ID: 12535303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin: an anticoagulant option for percutaneous coronary intervention.
    Bates ER
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):153-62. PubMed ID: 15151464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports.
    Manfredi JA; Wall RP; Sane DC; Braden GA
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):468-72. PubMed ID: 11285599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in acute anticoagulation therapy: what improvements over traditional heparin are on the horizon?
    Carter CJ
    Postgrad Med; 1996 Jun; 99(6):129-36. PubMed ID: 8668626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and other rapidly acting anticoagulants.
    Hyers TM
    Semin Vasc Surg; 2005 Sep; 18(3):130-3. PubMed ID: 16168887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.